CJC-1295 / Ipamorelin

CJC-1295 5mg / Ipamorelin 5mg Blend

Product Description CJC-1295 No DAC (Modified GRF 1-29) combined with Ipamorelin is a synergistic peptide blend that stimulates growth hormone (GH) release via complementary pathways. CJC-1295 No DAC acts as a short-acting GHRH analog, while Ipamorelin functions as a selective ghrelin mimetic (GHS). Supplied as a high-purity lyophilized powder blend (HPLC verified), it is designed for laboratory studies on GH pulsatility, recovery, metabolism, and body composition.

Key Research Mechanism This blend activates both GHRH and ghrelin receptors in the pituitary gland to promote natural, pulsatile GH secretion. CJC-1295 No DAC provides targeted GH pulses with a short half-life, while Ipamorelin amplifies GH release without significantly affecting cortisol or prolactin. Together, they support elevated GH and IGF-1 levels, enhancing protein synthesis, lipolysis, and tissue repair in research models.

Primary Research Areas

• Growth hormone pulsatility and IGF-1 elevation studies
• Muscle growth, recovery, and lean mass research
• Fat metabolism and body composition models
• Sleep architecture, tissue repair, and anti-aging pathways

Intended Use For in vitro and in vivo research only. Not for human or veterinary use. This product is sold strictly for scientific and laboratory investigation. Researchers must follow all institutional and regulatory guidelines. Not evaluated by the FDA.